NorthWest Biotherapeutics Inc (NWBO)

[survivor1x]

ICT 107 exclusion

Exclusion Criteria:

Recurrent disease
Radiosurgery including Gamma Knife, linear accelerator based radiosurgery, CyberKnife and placement of Gliadel wafer
Presence of any other active malignancy or prior history of malignancy (except for basal cell carcinoma of the skin)
Severe pulmonary, cardiac or other systemic disease
Congestive heart failure Class III or IV according to New York Heart Association (NYHA)
Presence of an acute infection requiring active treatment with antibiotics/antivirals; prophylactic administration is allowed
Known history of an autoimmune disorder
Known human immunodeficiency virus (HIV) positivity or acquired immunodeficiency syndrome (AIDS) related illness or other serious medical illness
Breastfeeding
Received any other therapeutic investigational agent within 30 days of enrollment
Reduction of steroids (dexamethasone) to a maximum of 2 mg twice a day (BID) prior to the first administration of study vaccine